Female Cialis Soft

Let’s talk about something that, for years, had a glaring gap in both research and practical clinical tools. We’re all familiar with phosphodiesterase type 5 (PDE5) inhibitors for men—sildenafil, tadalafil, the usuals. But when a significant number of female patients began presenting with distressing symptoms of acquired, generalized Hypoactive Sexual Desire Disorder (HSDD), often secondary to SSRIs or perimenopause, the toolbox felt embarrassingly sparse. We had counseling, hormone therapies with their own risk profiles, and the recently approved flibanserin, but the search for other pharmacologic options led to off-label use and a lot of experimentation.